Monday, July 16, 2007

Investors nervous about Pfizer's maraviroc launch.

Monogram Biosciences (MGRM) investors are getting mighty nervous. They depend on the launch of Pfizer's HIV drug, maraviroc, to sell a test used to identify patients that will respond to the new drug.

And they are starting to blame Question Authority for the slump in Monogram stock since this blog revealed allegations by a Pfizer insider about illegal premarketing.

Here is the message string from the investors.

One of them writes, "I'm looking into this Rost guy. I don't think it's a coincidence that MGRM starting tanking around the time this guy started posting on his blog (April). Of course, if the FDA would finally approve, this is all mute. "

More maraviroc stories here.

1 comment:

Anonymous said...

Congratulations, Doc! Those jerks at Pfizer Legal; Covington & Burling; Epstein something and who; and Dewey Cheatum & Howe have to stop pretending that the hype about you and your dramatic impact on companies, stocks and wrong-doing is somehow narcissistic and only in your own mind. Time after time, just like here, it's OUTSIDERS you don't even know who credit you with so much dramatic impact on companies, stocks and wrong-doing.

Keep up the good work. If the dark side is uncomfortable, it means you're doing your job!

P.S. Looks like this is an investor who needs to learn the difference between mute and moot. Perhaps he really meant mute, though. It sure sounds like he wants everyone/thing to shut up except for the bell on the stock exchange!